We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+17.63%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.7B
AUM Growth
+$43.5M
(+2.6%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-6.45%
Top 10 Holdings %
Top 10 Hldgs %
43.98%
Holding
67
New
4
Increased
4
Reduced
33
Closed
4
Top Buys
| 1 |
ORKA
Oruka Therapeutics
ORKA
|
+$14.3M |
| 2 |
BioNTech
BNTX
|
+$14.2M |
| 3 |
Regenxbio
RGNX
|
+$3.94M |
| 4 |
ATXS
Astria Therapeutics
ATXS
|
+$3.46M |
| 5 |
4D Molecular Therapeutics
FDMT
|
+$3.13M |
Top Sells
| 1 |
Krystal Biotech
KRYS
|
+$40.7M |
| 2 |
FOLD
Amicus Therapeutics
FOLD
|
+$25.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$10.2M |
| 4 |
Kymera Therapeutics
KYMR
|
+$8.21M |
| 5 |
Entrada Therapeutics
TRDA
|
+$7.99M |
Sector Composition
| 1 | Healthcare | 97.73% |
| 2 | Industrials | 2.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Krystal Biotech
KRYS
$10.2B
| $147M | 8.69% |
810,245
-210,833
| -21% | -$40.7M |
|
2
Nurix Therapeutics
NRIX
$2.45B
| $96.2M | 5.67% |
4,280,981
-142,635
| -3% | -$3.23M |
|
|
FOLD
3
DELISTED
Amicus Therapeutics
FOLD
| $88.1M | 5.19% |
8,246,592
-2,348,497
| -22% | -$25.6M |
|
4
Immunome
IMNM
$2.54B
| $71.5M | 4.21% |
4,889,554
| – | – |
|
|
5
Kymera Therapeutics
KYMR
$9.3B
| $65.9M | 3.88% |
1,393,256
-186,019
| -12% | -$8.21M |
|
6
Zymeworks
ZYME
$1.82B
| $64M | 3.77% |
5,101,911
-109,126
| -2% | -$1.19M |
|
7
Stoke Therapeutics
STOK
$1.84B
| $57.9M | 3.41% |
4,713,509
-7,545
| -0.2% | -$107K |
|
8
Replimune Group
REPL
$826M
| $52.4M | 3.09% |
4,781,183
-780,913
| -14% | -$7.93M |
|
9
Biohaven
BHVN
$2.23B
| $51.7M | 3.04% |
1,034,219
-53,357
| -5% | -$2.08M |
|
|
10
Regenxbio
RGNX
$622M
| $51.3M | 3.02% |
4,892,902
+323,100
| +7% | +$3.94M |
|
|
IGMS
11
DELISTED
IGM Biosciences
IGMS
| $50.8M | 2.99% |
3,072,478
| – | – |
|
12
ADC Therapeutics
ADCT
$158M
| $49.4M | 2.91% |
15,669,217
+400,000
| +3% | +$1.26M |
|
13
Cogent Biosciences
COGT
$6.67B
| $48.4M | 2.85% |
4,484,380
-315,593
| -7% | -$3.07M |
|
14
Fate Therapeutics
FATE
$336M
| $46.1M | 2.72% |
13,169,057
| – | – |
|
15
LivaNova
LIVN
$4.4B
| $46M | 2.71% |
875,039
-54,467
| -6% | -$2.7M |
|
16
Scholar Rock
SRRK
$6.47B
| $42M | 2.47% |
5,238,837
-214,246
| -4% | -$1.88M |
|
17
Neurogene
NGNE
$781M
| $40.5M | 2.38% |
964,347
-49,316
| -5% | -$1.91M |
|
|
AKRO
18
DELISTED
Akero Therapeutics
AKRO
| $39.8M | 2.35% |
1,387,479
-226,994
| -14% | -$5.92M |
|
19
Beam Therapeutics
BEAM
$3.13B
| $39.5M | 2.33% |
1,611,013
-92,048
| -5% | -$2.38M |
|
|
AUGX
20
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $38.5M | 2.27% |
16,380,327
| – | – |
|
21
Annexon
ANNX
$934M
| $38.1M | 2.24% |
6,427,462
| – | – |
|
|
CTLT
22
DELISTED
CATALENT, INC.
CTLT
| $36.1M | 2.13% |
595,570
| – | – |
|
23
Pliant Therapeutics
PLRX
$68.7M
| $35.8M | 2.11% |
3,197,491
-12,100
| -0.4% | -$151K |
|
|
SLN
24
Silence Therapeutics
SLN
$483M
| $34.5M | 2.03% |
1,899,317
-114,979
| -6% | -$2.14M |
|
25
Keros Therapeutics
KROS
$208M
| $32.1M | 1.89% |
552,506
| – | – |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO